Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2022Accounts of Chemical ResearchOpen Access

Atropisomerism in the Pharmaceutically Relevant Realm

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMariami BasilaiaMCMatthew H. ChenJSJim Secka

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Basilaia et al. (2022) studied this question.

synapsesocial.com/papers/69dedbc740ea065679559a74https://doi.org/10.1021/acs.accounts.2c00500
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exploiting Atropisomerism to Increase the Target Selectivity of Kinase Inhibitors2015 · 65 citations
  2. 2Atropisomerism in Medicinal Chemistry: Challenges and Opportunities2018 · 378 citations
  3. 3Leveraging Atropisomerism to Obtain a Selective Inhibitor of RET Kinase with Secondary Activities toward EGFR Mutants2019 · 31 citations
  4. 4Catalytic Atroposelective Synthesis of N -Aryl Quinoid Compounds2020 · 113 citations
  5. 5LXXI.—The molecular configurations of polynuclear aromatic compounds. Part I. The resolution of γ-6 : 6′-dinitro- and 4 : 6 : 4′ : 6′-tetranitro-diphenic acids into optically active components1922 · 263 citations